Improved dissolution of oleanolic acid with ternary solid dispersons

AAPS PharmSciTech

Volumn 8, Issue 4, 2007, Pages

  Liu, Longxiao ^a   Wang, Xiaocui ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Oleanolic acid; Polysorbate 80; PVPk30; Ternary solid dispersions

Indexed keywords

DRUG CARRIER; OLEANOLIC ACID; POLYSORBATE 80; POVIDONE; SURFACTANT; POLYSORBATE;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; CHEMISTRY; KINETICS; METHODOLOGY; PHARMACEUTICS; SOLUBILITY;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG CARRIERS; DRUG COMPOUNDING; KINETICS; OLEANOLIC ACID; POLYSORBATES; POVIDONE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 38049115564     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Liu J. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol. 1995;49:57-68.
2. Mahato SB, Sarkar SK, Poddar G. Triterpenoid saponins. Phytochemistry. 1988;27:3037-3067.
3. Tang HQ, Hu J, Yang L, et al. Terpenoids and flavonoids from Artemisia species. Planta Med. 2000;66:391-393.
4. Jeong TS, Hwang EI, Lee HB, et al. Chitin synthase II inhibitory activity of ursolic acid isolated from Crataegus pinnatifida. Planta Med. 1999;65:261-263.
5. Song M, Hang TJ, Wang Y, et al. Determination of oleanolic acid in human plasma and study of its pharmacokinetics in Chinese healthy male volunteers by HPLC tandem mass spectrometry. J Pharm Biomed Anal. 2006;40:190-196.
6. Damian F, Blaton N, Naesens L, et al. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci. 2000;10:311-322.
7. Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci. 1971;60:1281-1302.
8. Ford JL. The current status of solid dispersions. Pharm Acta Helv. 1986;61:69-88.
9. Craig DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 2002;231:131-144.
10. Abdul-Fattah AM, Bhargava HN. Preparation and in vitro evaluation of solid dispersions of halofantrine. Int J Pharm. 2002;235:17-33.
11. Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm. 2004;272:1-10.
12. Serajuddin ATM. Solid dispersion of poor water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999;88:1058-1066.
13. Serajuddin ATM, Sheen PC, Augustine MA. Improved dissolution of a poorly water-soluble drug from solid dispersions in poly (ethylene glycol): polysorbae 80 mixtures. J Pharm Sci. 1990;79:463-464.
14. Morris KR, Knipp GT, Serajuddin ATM. Structural properties of poly (ethylene glycol)-polysorbate 80 mixture, a solid dispersion vehicle. J Pharm Sci. 1992;81:1185-1188.
15. Wulff M, Alden M, Craig DQM. An investigation into the critical surfactant concentration for solid solubility of hydrophobic drug in different polyethylene glycols. Int J Pharm. 1996;142:189-198.
16. Mura P, Faucci MT, Manderioli A, et al. Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions. Drug Dev Ind Pharm. 1999;25:257-264.
17. Dannenfelser RM, He H, Joshi Y, et al. Development of clinical dosage forms of a poorly water soluble drug I: application of polyethylene glycol-polysorbate80 solid dispersion carrier system. J Pharm Sci. 2004;93:1165-1175.
18. Kearney AS, Gabriel DL, Mehta SC, et al. Effect of polyvinyl pyrrolidone on the crystallinity and dissolution rate of solid dispersions of the antiinflammatory Ci-987. Int J Pharm. 1994;104:169-174.
19. El-Zein H, Riad L, El-bary AA. Enhancement of carbamazepine dissolution: in vitro and in vivo evaluation. Int J Pharm. 1998;168:209-220.
20. USP. The United States Pharmacopeia (USP) XXIX. NF XXIV. Rockville, MD: United States Pharmacopeial Convention Inc.; 2006:2673-2673.
21. Matsumoto T, Zografi G. Physical properties of solid molecular dispersions of indomethacin with poly-(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinylacetate) in relation to indomethacin crystallization. Pharm Res. 1999;16:1722-1728.
22. Van den Mooter G, Wuyts M, Blaton N, et al. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci. 2001;12:261-269.
23. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000; 50:54-55.
24. Okonogi S, Puttipipatkhachorn S. Dissolution improvement of high drug-loaded solid dispersion. AAPS PharmSciTech. 2006; 7:E52.